Regulation of gene expression by activation of the peroxisome proliferator-activated receptor γ with rosiglitazone (BRL 49653) in human adipocytes

被引:115
作者
Rieusset, J
Auwerx, J
Vidal, H
机构
[1] Univ Lyon 1, INSERM U449, Fac Med Rene Laennec, F-69372 Lyon 08, France
[2] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch, France
关键词
D O I
10.1006/bbrc.1999.1657
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To better define the mechanism of action of the thiazolidinediones, we incubated freshly isolated human adipocytes with rosiglitazone and investigated the changes in mRNA expression of genes encoding key proteins of adipose tissue functions. Rosiglitazone (10(-6) M, 4 h) increased p85 alpha phosphatidylinositol 3-kinase (p85 alpha PI-3K) and uncoupling protein-2 mRNA levels and decreased leptin. expression. The mRNA levels of insulin receptor, IRS-1, Glut 4, lipoprotein lipase, hormone-sensitive lipase, acylation-stimulating protein, fatty acid transport protein-1, angiotensinogen, plasminogen activator inhibitor-1, and PPAR gamma 1 and gamma 2 were not modified by rosiglitazone treatment. Activation of RXR, the partner of PPAR gamma, in the presence of rosiglitazone, increased. further p85 alpha PI-3K and UCP2 mRNA levels and produced a significant augmentation of Glut 4 expression. Because p85 alpha PI-3K is a major component of insulin action, the induction of its expression might explain, at least in part, the insulin-sensitizing effect of the thiazolidinediones. (C) 1999 Academic Press.
引用
收藏
页码:265 / 271
页数:7
相关论文
共 55 条
[1]   Defective regulation of phosphatidylinositol-3-kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent diabetes mellitus patients [J].
Andreelli, F ;
Laville, M ;
Ducluzeau, PH ;
Vega, N ;
Vallier, P ;
Khalfallah, Y ;
Riou, JP ;
Vidal, H .
DIABETOLOGIA, 1999, 42 (03) :358-364
[2]   Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients [J].
Auboeuf, D ;
Rieusset, J ;
Fajas, L ;
Vallier, P ;
Frering, V ;
Riou, JP ;
Staels, P ;
Auwerx, J ;
Laville, M ;
Vidal, H .
DIABETES, 1997, 46 (08) :1319-1327
[3]  
Auboeuf D, 1997, ANAL BIOCHEM, V245, P141, DOI 10.1006/abio.1996.9986
[4]  
Auwerx J, 1999, CELL, V97, P161
[5]   Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: Binding and activation correlate with antidiabetic actions in db/db mice [J].
Berger, J ;
Bailey, P ;
Biswas, C ;
Cullinan, CA ;
Doebber, TW ;
Hayes, NS ;
Saperstein, R ;
Smith, RG ;
Leibowitz, MD .
ENDOCRINOLOGY, 1996, 137 (10) :4189-4195
[6]   An antidiabetic thiazolidinedione potentiates insulin stimulation of glycogen synthase in rat adipose tissue [J].
Berger, J ;
Biswas, C ;
Hayes, N ;
Ventre, J ;
Wu, M ;
Doebber, TW .
ENDOCRINOLOGY, 1996, 137 (05) :1984-1990
[7]  
BONINI JA, 1995, AM J PHYSIOL, V269, pF759
[8]   Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat [J].
Braissant, O ;
Foufelle, F ;
Scotto, C ;
Dauca, M ;
Wahli, W .
ENDOCRINOLOGY, 1996, 137 (01) :354-366
[9]   Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissues and skeletal muscle [J].
Camirand, A ;
Marie, V ;
Rabelo, R ;
Silva, JE .
ENDOCRINOLOGY, 1998, 139 (01) :428-431
[10]   PPARγ activators down-regulate the expression of PPARγ in 3T3-L1 adipocytes [J].
Camp, HS ;
Whitton, AL ;
Tafuri, SR .
FEBS LETTERS, 1999, 447 (2-3) :186-190